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Abstract
Multiple sclerosis is a chronic, inflammatory, demyelinating disease of the central nervous system in which macrophages
and microglia play a central role. Foamy macrophages and microglia, containing degenerated myelin, are abundantly found
in active multiple sclerosis lesions. Recent studies have described an altered macrophage phenotype after myelin
internalization. However, it is unclear by which mechanisms myelin affects the phenotype of macrophages and how this
phenotype can influence lesion progression. Here we demonstrate, by using genome wide gene expression analysis, that
myelin-phagocytosing macrophages have an enhanced expression of genes involved in migration, phagocytosis and
inflammation. Interestingly, myelin internalization also induced the expression of genes involved in liver-X-receptor
signaling and cholesterol efflux. In vitro validation shows that myelin-phagocytosing macrophages indeed have an
increased capacity to dispose intracellular cholesterol. In addition, myelin suppresses the secretion of the pro-inflammatory
mediator IL-6 by macrophages, which was mediated by activation of liver-X-receptor b. Our data show that myelin
modulates the phenotype of macrophages by nuclear receptor activation, which may subsequently affect lesion
progression in demyelinating diseases such as multiple sclerosis.
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Introduction
One of the pathological hallmarks of multiple sclerosis (MS) is
loss of the nerve-insulating myelin sheath, which contributes to the
myriad of symptoms observed in individuals with MS. Infiltrated
macrophages and resident microglia are considered to be the
primary effector cells in MS and its animal model, experimental
autoimmune encephalomyelitis (EAE) [1–3]. Together with
activated autoreactive lymphocytes they orchestrate the immuno-
pathological processes causing demyelination and concomitant
axonal degeneration [4–7]. In addition to the secretion of cytotoxic
cytokines or soluble toxic mediators [8–13], microglia and
infiltrated macrophages phagocytose and degrade myelin [14–
22]. Although presumably detrimental when considering degener-
ation of intact myelin, clearance of myelin debris has also been
reported to be a prerequisite for axonal remyelination [23–25].
Recently, macrophages, microglia and dendritic cells have been
described to adopt an altered phenotype following myelin
phagocytosis. Nonetheless, the effect myelin has on the inflam-
matory state of these cells remains controversial. Several studies
have reported, for instance, a neuroinflammatory phenotype of
macrophages and microglia after myelin internalization, charac-
terized by an increased production of pro-inflammatory and toxic
mediators [14–16,20]. In contrast, other studies describe that
monocyte-derived macrophages, peritoneal macrophages, microg-
lia and dendritic cells obtain anti-inflammatory characteristics
following internalization of myelin [17–19,22,26].
This study aims to determine the phenotype of myelin-
phagocytosing macrophages (mye-macrophages) in a pro-inflam-
matory environment, similar to which they are exposed to in the
parenchyme and perivascular spaces during active demyelination
in MS [27–29]. Microarray analysis discovered 676 differentially
regulated genes in mye-macrophages compared to control
macrophages, both treated with IFNc and IL-1b. Gene ontology
and pathway mapping tools demonstrated an overrepresentation
of genes in pathways involved in proliferation, chemotaxis,
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phagocytosis, inflammation, lipid metabolism and liver X receptor
(LXR) signaling. Quantitative PCR validated that several genes
involved in lipid metabolism and LXR signaling were differentially
regulated in mye-macrophages. These alterations in gene expres-
sion have functional consequences as mye-macrophages showed
an increased efflux of cholesterol. LXR activation has been
described to increase the expression of genes involved in lipid
metabolism and to suppress inflammation related genes in
macrophages. We show that myelin suppresses the macrophage-
mediated production of the pro-inflammatory mediator IL-6 by
activating the liver X receptor b-isoform. These results indicate
that myelin possesses functional ligands capable of activating
LXRs, hereby affecting the phenotype of macrophages.
Methods
Animals
Wistar rats were purchased from Harlan Netherlands B.V.
(Horst, The Netherlands). Wild-type, LXRa-KO, LXRb-KO and
LXRab-KO mice have been described previously [30]. Animals
were housed in the animal facility of the Biomedical Research
Institute of Hasselt University. Experiments were conducted in
accordance with institutional guidelines and were approved by the
ethical committee for animal experiments of Hasselt University.
Myelin Isolation
Myelin was purified from rat and mouse brain tissue by means
of density-gradient centrifugation, as described previously [31].
Myelin protein concentration was determined by using the BCA
protein assay kit (Thermo Fisher Scientific, Erembodegem,
Belgium). Endotoxin content was determined using the Chromo-
genic Limulus Amebocyte Lysate assay kit (Genscript Incorpera-
tion, Aachen, Germany). Isolated myelin contained a neglectable
amount of endotoxin (#1.861023 pg/mg myelin).
Cell Culture
Resident peritoneal macrophages were obtained by peritoneal
lavage using ice-cold PBS (Lonza, Vervier, Belgium) supplemented
with 5 mM EDTA (VWR, Leuven, Belgium). Peritoneal exudate
cells were cultured for 2 hours in RPMI 1640 medium (Invitrogen,
Merelbeke, Belgium). After a 2 hour incubation at 37uC with 5%
CO2, non-adherent cells were washed away. Remaining cells were
.95% macrophages [32].
For microarray analysis isolated macrophages were seeded in
flat-bottom 12-well plates (16106 cells/ml) in RPMI 1640 medium
supplemented with 50 U/ml streptomycin (Invitrogen), 50 U/ml
streptomycin (Invitrogen) and 10% FCS (Hyclone, Erembodegem,
Belgium), and treated with 100 mg/ml of isolated myelin (n = 5) or
left untreated (n= 5). Following a three day culture, myelin was
removed by washing twice with RPMI 1640 medium at 37uC.
Subsequently, cells were treated with 100 ng/ml IFNc and IL-1b
(Preprotech, London, UK) for 9 hours. For validation experiments
isolated macrophages were treated for 24 or 48 hours with
100 mg/ml of isolated myelin or 10 mM T0901317 (T09; Cayman
Chemicals, Huissen, The Netherlands).
RNA Isolation
Total RNA was prepared using the RNeasy mini kit (Qiagen,
Venlo, The Netherlands), according to the manufacturer’s
instructions. The RNA concentration and quality was determined
with a NanoDrop spectrophotometer (Isogen Life Science,
IJsselstein, The Netherlands).
Microarray Analysis
RNA was labeled and hybridized to Affymetrix rat 230–2.0
GeneChips (Affymetrix, UK) containing 31000 probe sets which
analyze the expression level of over 30000 transcripts and variants
from over 28000 well-substantiated rat genes. Hybridized chips
were stained, washed and scanned with GeneChip Scanner 3000.
All steps were carried out according to the standard Affymetrix
protocols.
Raw Affymetrix CEL files from five replicates for each
condition were collected. Bioconductor packages running under
the R platform were used to process raw data [33]. By using the
affy package [34], raw data were pre-processed to obtain RMA
expression values [35]. Variance-based non-specific filtering was
performed using the genefilter package to remove 50% of the
probe sets, corresponding to those exhibiting the smallest
variations in expression across the samples. Filtered genes that
are differentially expressed between the two conditions were
identified using unpaired two-sample T test. All data are MIAME
compliant and the raw data have been deposited in NCBI’s Gene
Expression Omnibus [36], accessible through GEO series
accession number GSE34811.
The Database for Annotation, Visualization and Integrated
Discovery (DAVID, http://david.abcc.ncifcrf.gov/) was used to
determine enriched molecular functions/biological processes (ease
score ,0.01) and KEGG-pathways (ease score ,0.1) in both the
up- and downregulated gene pool [37]. DAVID utilizes a modified
Fisher’s exact test to measure the gene enrichment in annotation
terms (EASE score). In parallel, gene-pools were analyzed through
the use of Ingenuity Pathway Analysis (IPA, IngenuityH Systems,
www.ingenuity.com). Overrepresented biological functions and
canonical pathways with a Fisher exact p-value of ,0.02 were
considered significant. Overlapping functional categories and
related genes in the output of both pathway analysis tools were
utilized for further functional characterization.
Quantitative PCR
RNA was converted to cDNA using the reverse transcription
system (Promega, Leuven, Belgium). In brief, RNA was supple-
mented with MgCl2 (25 mM), RTase buffer (106), DNTP mixture
(10 mM); RNasin (20–40 U/ml); AMV RTase (20 U/ml) Oligo(dt)
15 primer and nuclease free water. The reverse transcription
reaction was performed on 42uC for 60 minutes, 95uC for 5
minutes, using the iCYCLER (Biorad Benchmark). Quantitative
PCR was conducted on a 7500 fast detection system (Applied
biosystems, Gaasbeek, Belgium) using universal cycling conditions
(10 min 95uC, 40 cycles of 15 s at 95uC and 60 s at 60uC). The
PCR reaction consisted of fast SYBR green master mix (Applied
biosystems), 10 mM of forward and reverse primers, RNase free
water and 12.5 ng template cDNA in a total reaction volume of
10 ml. PCR products were loaded on 1.5% agarose gels to confirm
specificity of amplification and the absence of primer dimer
formation. Relative quantification of gene expression was accom-
plished by using the comparative Ct method. Data were
normalized to the most stable reference genes, as previously
described [38,39]. In our experimental setup, geNorm identified
PGK1 and 18S as the most stable combination of reference genes
with an identical M-value of 0.09 (data not shown). Additionally,
by analyzing the pairwise variation value, Vn/n+1, we demonstrat-
ed that in our data set two reference genes were sufficient for
normalization, since inclusion of an additional reference gene
increases the pairwise variation value (data not shown). Primers
were chosen according to literature or designed using Primer-
Express (http://www.ncbi.nlm.nih.gov/tools/primer-blast). De-
tails of primers used are shown in table S1.
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Cholesterol Efflux Assay
Following isolation, macrophages were seeded in 24-well plates
and incubated for 48 hours with 0.5 mCi/ml 1,2- [3H] cholesterol
(GE Healthcare, UK). Next, cells were washed and treated with
myelin or left untreated. Following 24 hours incubation, cells were
washed with PBS, after which RPMI-1640 supplemented with
penicillin/streptomycin and 50 mg/ml HDL (VWR) was added for
6 hours. Cholesterol efflux was analyzed using a b-plate liquid
scintillation counter (Wallac, Turku, Finland). In addition,
cholesterol efflux was determined using the Amplex Red
Cholesterol Assay Kit (Invitrogen), according the manufacturer’s
instructions.
Nitrite Formation and IL-6 Production
Culture supernatants of rat or mouse macrophages treated for
24, 48 or 72 hours with 100 mg/ml myelin or 10 mM T09 were
collected after 18 hour stimulation with 100 ng/ml LPS (Sigma-
Aldrich, Bornem, Belgium) or 100 ng/ml IFNc/IL-1b (Prepro-
tech). Release of NO and IL-6 was determined using a griess
reagent system (Promega) and an IL-6 ELISA (R&D systems,
Abingdon, UK) respectively.
Statistical Analysis
Data were statistically analyzed using GraphPad Prism for
windows (version 4.03) and are reported as mean6SEM.
D’Agostino and Pearson omnibus normality test was used to test
normal distribution. An ANOVA or two-tailed unpaired student
T-test (with Welch’s correction if necessary) was used for normally
distributed data sets. The Kruskal-Wallis or Mann-Whitney
analysis was used for data sets which did not pass normality.
*P,0,05, **P,0,01 and ***P,0,001.
Results
Differentially Regulated Genes, Biological Processes and
Pathways in Mye-macrophages
The transcriptional events, associated with myelin phagocytosis
by macrophages in a pro-inflammatory environment, were
investigated using Affymetrix rat 230–2.0 GeneChips. Non-
phagocytosing macrophages stimulated with IFNc and IL-1b
were used as control cells. The expression levels of individual genes
were compared between groups using Bioconductor packages
running under the R platform (see methods for details).
Differentially expressed genes, their p-values and fold changes
are listed in table 1 (complete list in table S2). Employing the
cutoffs described in the methods section, the expression of 676
genes was altered, from which 280 genes were upregulated and
396 were downregulated.
To investigate the biological interactions of the genes identified
in our screen, differentially expressed genes were further analyzed
using pathway analysis software. IPA was used to determine
overrepresented biological functions and canonical pathways
within the up- and downregulated genes. Respectively 7 and 15
overrepresented canonical pathways were identified in the up- and
downregulated gene pool (table 2). Canonical pathways in the
upregulated gene pool included: aminosugar metabolism
(p = 0.0002, genes: GCK, HEXB, PDE7B, PDE7A, PDE8B and
TULP2), peroxisome proliferator-activated receptor (PPAR) sig-
naling (p = 0.004, genes: FOS, HSP90AB1, PDGFRB, RRAS2
and RXRa), complement system (p= 0.007, genes: C1QA, CFH
and C8A), LXR/retinoid X receptor (RXR) activation (p = 0.009,
genes: ABCG1, APOA1, RXRa and RXRc) and cyclic adenosine
monophosphate (cAMP) mediated signaling (p = 0.01, genes:
CHRM1, HTR6, PDE7B, PDE7A, PDE8B, PKIA and TULP2).
Overrepresented pathways in the downregulated gene pool
included: p53 signaling (p= 0.0009, genes: CCND2, CDKN1A,
HDAC1, HIPK2, MDM2, MED1 and PIK3C2A), mammalian
target of rapamycin (mTOR) signaling (p = 0.005, genes:
AKT1S1, EIF4A2, FNBP1, PDPK1, PIK3C2A, RPS6KA1,
RPS6KA5 and STK11), cell cycle checkpoint regulation
(p = 0.008, genes: CCNB1, CDKN1A, MDM2 and RPS6KA1),
ciliary neurotrophic factor (CNTF) signaling (p = 0.01, genes:
IL6ST, PIK3C2A, RPS6KA1 and RPS6KA5), ras homolog gene
family member A (RhoA) signaling (p = 0.01, genes: ARHGAP5,
GRLF1, MYLPF, PPP1R12A, RDX and ROCK2) and IL-8
signaling (p = 0.01, genes: ANGPT2, CCND2, FNBP1, GNAI2,
IRAK1, PAK2, PIK3C2A and ROCK2). In concordance, IPA
identified significantly overrepresented molecular and cellular
functions related to these canonical pathways (table 2).
For comparison, data were additionally analyzed with DAVID
(table S3). Like IPA, DAVID identified genes functionally
clustered in various categories of KEGG pathways, biological
processes and molecular functions. Using the cutoffs described in
the methods section, DAVID identified similar enriched pathways
and biological processes as IPA.
The 9-fold upregulation of myelin basic protein (MBP) was not
due to RNA contamination of myelin, since added myelin
contained a negligible amount of RNA (data not shown). Golli-
MBP immunoreactivity has been reported in microglia and central
nervous system (CNS) infiltrating macrophages in EAE affected
animals [40].
Quantitative PCR Validation of Differentially Expressed
Genes
The microarray data demonstrate that there is an overrepre-
sentation of genes in processes like lipid-metabolism, LXR/PPAR
signaling and cholesterol efflux in mye-macrophages. This suggests
that myelin activates LXRs and/or PPARs in macrophages,
hereby increasing the expression of response genes which are
involved in lipid metabolism and cholesterol efflux. To confirm the
capacity of myelin to act as an activator of LXR/PPAR signaling,
expression of several LXR/PPAR regulated and related genes, like
ATP-binding cassette transporter A1/G1 (ABCA1/ABCG1),
RXRa/b/c and stearyl-CoA desaturase 1/2 (SCD1/SCD2), was
validated by means of qPCR (figure 1). All genes were found to be
regulated in a similar manner as in the microarray analysis.
Findings were confirmed by additional qPCR experiments using
independent samples (data not shown). These results demonstrate
that myelin-derived lipids induce the expression of LXR/PPAR
response genes.
Mye-macrophages have an Increased Capacity to
Dispose Intracellular Cholesterol
ATP-binding cassette transporter A1 and G1 (ABCA1/ABCG1)
are pivotal in facilitating reverse cholesterol transport. They
mediate the transfer of intracellular cholesterol and phospholipids
to lipid-poor apolipoproteins and mature high-density lipoprotein
(HDL) [41–45]. As mye-macrophages showed an increased
expression of both transporters, we determined whether mye-
macrophages are more potent in disposing intracellular cholesterol
than control macrophages. As expected, mye-macrophages display
an increased cholesterol efflux when HDL is used as an acceptor
(figure 2). Similar results were obtained when using the Amplex
Red Cholesterol Assay Kit, which measures both free cholesterol
and cholesterylesters (data not shown). Collectively, these results
show that the increased expression of genes involved in cholesterol
LXR Activation in Myelin-Phagocytosing Macrophages
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metabolism has functional consequences, as mye-macrophages
display an increased capacity to dispose intracellular cholesterol.
Myelin Alters the Macrophage Phenotype by Activating
the LXRb Isoform
In addition to modulating cholesterol metabolism, LXRs have
been described to negatively regulate macrophage inflammatory
gene expression [46–50]. Since myelin is a rich source of
cholesterol and cholesterol metabolites are natural ligands for
Table 1. Top 20 up- and downregulated genes in mye-macrophages.
Affy ID Gene name Gene symbol FC P value
Upregulated genes
1368810_a_at Myelin basic protein MBP 9.12 0.001
1367668_a_at Stearoyl-CoA desaturase (delta-9-desaturase) Scd 4.02 0.027
1373098_at Breast carcinoma amplified sequence 1 BCAS1 3.81 0.007
1368103_at ATP-binding cassette, sub-family G, member 1 ABCG1 2.40 0.045
1375077_at N/A N/A 1.77 0.009
1376652_at Complement component 1, q subcomponent C1qa 1.75 0.039
1382153_at C-type lectin, superfamily member 6 Clescf6 1.64 0.046
1398262_at Phosphoribosyl pyrophosphate synthetase 2 Prps2 1.63 0.004
1391665_at Fibroblast growth factor 7 Fgf7 1.53 0.009
1382431_at ATP-binding cassette, sub-family A, member 1 ABCA1 1.52 0.023
1384534_at GRAM domain containing 3 GRAMD3 1.48 0.038
1380245_at N/A N/A 1.45 0.024
1394673_at Similar to Myeloid cell surface antigen CD33 LOC687856 1.44 0.002
1370423_at Guanine nucleotide binding protein, alpha 15 GNA15 1.44 0.029
1373150_at Catechol-O-methyltransferase domain containing 1 COMTD1 1.44 0.036
1375932_at Phosphoribosyl pyrophosphate synthetase 2 Prps2 1.43 0.008
1372818_at Collectin sub-family member 12 Colec12 1.41 0.043
1376155_at Family with sequence similarity 151, member B FAM151B 1.41 0.032
1374746_at Ab1-152 LOC500877 1.41 0.008
1390987_at N/A N/A 1.40 0.021
Downregulated genes
1392838_at Similar to CG13957-PA RGD1309995 0.47 0.016
1369067_at Nuclear receptor subfamily 4, group A, member 3 Nr4a3 0.47 0.009
1398846_at Eukaryotic translation initiation factor 5 EIF5 0.47 0.033
1394935_at WAS protein family, member 2 Wasf2 0.48 0.019
1369481_at Tumor necrosis factor superfamily, member 4 TNFSF4 0.49 0.042
1396225_at Cytoplasmic polyadenylation binding protein 2 CPEB2 0.49 0.011
1376739_at DEAD (Asp-Glu-Ala-Asp) box polypeptide 24 DDX24 0.51 0.008
1395154_at Zinc finger CCCH type containing 13 ZC3H13 0.52 0.019
1380144_at Mps One Binder kinase activator-like 1A/B (yeast) MOBKL1A/B 0.53 0.015
1395923_at Nipped-B homolog (Drosophila) Nipbl 0.53 0.013
1395697_at Enhancer of zeste homolog 2 (Drosophila) Ezh2 0.54 0.029
1377151_at N/A N/A 0.54 0.011
1381809_at Ankyrin repeat domain 11 Ankrd11 0.55 0.005
1387391_at Cyclin-dependent kinase inhibitor 1A (p21, Cip1) CDKN1A 0.55 0.038
1391701_at MYST histone acetyltransferase 3 MYST3 0.55 0.013
1375453_at Hypothetical protein LOC688211 LOC688211 0.56 0.006
1398217_at Zinc finger and BTB domain containing 41 Zbtb41 0.56 0.033
1380446_at Myeloid/lymphoid or mixed-lineage leukemia 10 Mllt10 0.56 0.005
1381993_at Chloride intracellular channel 2 CLIC2 0.57 0.026
1374594_at Similar to RIKEN cDNA 1600029D21 LOC363060 0.57 0.035
doi:10.1371/journal.pone.0044998.t001
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LXRs, we evaluated whether myelin affects LXR response gene
expression and the secretion of pro-inflammatory mediators in a
similar manner as an LXR ligand. LXR response gene expression
was determined after treatment with myelin or a synthetic LXR
agonist (T0901317). We observed that myelin induced apolipo-
protein E (ApoE), ABCA1 and ABCG1 expression in macrophag-
es in a similar manner as T0901317 (figure 3a–c), suggesting that
myelin contains ligands capable of activating the LXR pathway.
To ascertain a myelin-mediated activation of LXRs, LXRa-,
LXRb- and LXRab-deficient mouse macrophages were treated
with myelin after which ABCA1 gene expression was determined.
Here we show that ABCA1 gene induction by myelin is reduced in
LXRb-deficient macrophages, while it is completely absent in
LXRab-KO macrophages. These results indicate that myelin
activates LXRs in macrophages.
To further elucidate the role of LXRs we determined the
influence of myelin and T0901317 on the secretion of inflamma-
tory mediators by macrophages. Both T0901317 and myelin
lowered the LPS or IFNc/IL-1b induced production of NO and
IL-6 to a similar extent (figure 4a–d). The reduction in NO and
IL-6 production was not due to a reduced viability of myelin- or
T0901317-treated macrophages (data not shown). To determine
the role of both the LXRa and LXRb isoform in the observed
effects, LXRa-, LXRb- and LXRab-deficient mouse macrophag-
es were used. We observed that lack of LXRb partially abolishes
the myelin induced suppression of IL-6 secretion, which was not
influenced by LXRa depletion (figure 4f). However, the reduction
of NO production by myelin was not significantly affected in both
LXRa-, LXRb- and LXRab macrophages (figure 4e), indicating
that besides LXRs other pathways are involved in the regulation of
the macrophage phenotype after myelin phagocytosis. Collective-
Table 2. Overrepresented canonical pathways and biological functions (IPA).
Downregulated gene pool Upregulated gene pool
Canonical pathways
p53 Signaling Aminosugars Metabolism
mTOR Signaling Thyroid Cancer Signaling
Growth Hormone Signaling PPAR Signaling
Cell Cycle: G2/M DNA Damage Regulation Relaxin Signaling
CNTF Signaling Complement System
Nur77 Signaling in T Lymphocytes LXR/RXR Activation
FLT3 Signaling in Hematopoietic Progenitor Cells cAMP-mediated Signaling
RhoA Signaling
Interleukin-8 Signaling
Regulation of eIF4 and p70S6K Signaling
ATM Signaling
Molecular and cellular functions
Cellular Development Carbohydrate Metabolism
Gene Expression Amino Acid Metabolism
Cell-To-Cell Signaling and Interaction Cellular Compromise
Cellular Growth and Proliferation Gene Expression
Cellular Function and Maintenance Nucleic Acid Metabolism
Protein Synthesis Small Molecule Biochemistry
Cell Morphology Cell Cycle
Cell Cycle Cell Signaling
Cellular Assembly and Organization Lipid Metabolism
DNA Replication, Recombination, and Repair Molecular Transport
Cellular Compromise Antigen Presentation
Amino Acid Metabolism Cell-To-Cell Signaling and Interaction
Post-Translational Modification Cellular Assembly and Organization
Small Molecule Biochemistry Cellular Growth and Proliferation
Cell Death DNA Replication, Recombination, and Repair
Antigen Presentation Cellular Development
Carbohydrate Metabolism Cellular Function and Maintenance
Lipid Metabolism Cell Morphology
Cell Signaling Cell Death
Nucleic Acid Metabolism
Cellular Movement
doi:10.1371/journal.pone.0044998.t002
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ly, these results indicate that myelin possesses functional ligands
capable of activating LXRb, hereby affecting the inflammatory
state of macrophages.
Discussion
To obtain insight into the influence of myelin internalization on
the functional phenotype of macrophages and the mechanisms
involved, the gene expression profile of mye-macrophages was
assessed. Microarray analysis revealed that the expression of 676
genes differed significantly. Gene ontology mapping and pathway
analysis identified several common enriched pathways related to
lipid metabolism, LXR/PPAR signaling and cholesterol efflux.
In addition to the upregulation of pathways related to lipid
metabolism, mye-macrophages showed an overrepresentation of
downregulated genes in pathways involved in proliferation, like
p53 signaling and cell cycle checkpoint regulation. The reduced
expression of p53 target genes, such as MDM2 and CDKN1A
(p21) [51–53], and HIPK2, a kinase important for p53-dependent
gene transcription [54,55], suggests that mye-macrophages have a
reduced transcriptional activity of p53. Moreover, as p21 regulates
cell cycle arrest, these results suggest that myelin has pro-
proliferative effects on macrophages.
Chemotaxis plays a pivotal role in the recruitment of monocytes
towards the CNS in MS and EAE. Moreover, the presence of
myelin-antigen containing phagocytes in CNS draining lymph
nodes in MS and EAE suggests that macrophages migrate to
lymph nodes after myelin internalization [56,57]. Microarray
analysis showed that mye-macrophages exhibit an overrepresen-
tation of downregulated genes in pathways like mTOR, IL-8 and
RhoA signaling, suggesting an altered motility of macrophages
after myelin ingestion [58–64]. These results are in line with a
recent report showing an aberrant motility of myelin-containing
macrophages [65].
In addition to controlling chemotaxis, mTOR and RhoA
signaling are reported to influence demyelination, by affecting
complement receptor-mediated phagocytosis [59,66]. Similarly,
the upregulated expression of C1q in mye-macrophages may
augment their phagocytic capacity [67,68]. These results indicate
that myelin uptake induces a positive feedback loop in macro-
phages, promoting myelin phagocytosis. Furthermore, alterations
in mTOR, complement and cAMP-mediated signaling have been
described to modulate the inflammatory properties of macrophag-
es [69–73]. The latter indicates a complex regulatory network
directing the specific phenotype of mye-macrophages.
Besides affecting cholesterol metabolism, the upregulated
expression of GCK and HEXB, genes involved in the aminosugar
metabolism pathway, indicates that sphingolipids and hexose
structures are also actively metabolized after myelin internalization
by macrophages [74,75]. This is in correspondence with related
differentially regulated (non-significant) pathways in the IPA
analysis, like sphingolipid (p = 0.52), galactose (p = 0.11), sucrose
Figure 1. Quantitative PCR validation. Comparison of fold changes between IFNc/IL1b-stimulated untreated (n = 5) and myelin treated
macrophages (n = 5). Relative quantification of gene expression (SCD1/2, ABCA1/G1 and RXRa/b/c) was accomplished by using the comparative Ct
method. Data were normalized to the most stable reference genes, determined by Genorm (18S and PGK1).
doi:10.1371/journal.pone.0044998.g001
Figure 2. Mye-macrophages have an increased capacity to
transfer intracellular cholesterol towards HDL. Macrophages
were loaded for 48 hours with 1,2- [3H] cholesterol after which cells
were treated with myelin for 24 hours or left untreated. HDL was used
as cholesterol acceptor. The relative cholesterol efflux is defined as the
amount of transported cholesterol in culture medium of mye-
macrophages divided by values in control macrophage cultures. Data
represent the mean of four independent experiments.
doi:10.1371/journal.pone.0044998.g002
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(p = 0.19), fructose and mannose (p = 0.15) metabolism. Interest-
ingly, sphingolipids are described to modulate inflammation and
the functional phenotype of macrophages [76,77], suggesting that
the phenotype of mye-macrophages may also be affected via this
pathway.
Intracellular lipid sensors like LXRs, which are activated by
cholesterol derivates, have recently been described as key
regulators of lipid metabolism and inflammation [78–80]. There
are two LXR isoforms termed a and b with considerable sequence
homology. Furthermore, they respond to the same endogenous
ligands and activate almost identical target genes. However, an
important distinction is their tissue distribution. LXRb is
ubiquitously expressed whereas LXRa is highly expressed in the
liver and at somewhat lower levels in the adrenal glands, intestine,
adipose tissue, macrophages, lung and kidney. Upon activation,
LXRs form heterodimers with RXRs and promote transcriptional
activation of response genes, like ABCA1, ABCG1 and SCD [81–
83]. Both microarray analysis and qPCR demonstrated an
increased expression of potential transcriptional partners of LXRs,
e.g. RXRa and RXRc. Additionally, ABCA1, ABCG1 and SCD2
were found to be upregulated in mye-macrophages. These results
suggest that myelin acts as an LXR-RXR heterodimer-selective
agonist.
ABCA1 and ABCG1 promote the efflux of cholesterol to
respectively APO-AI and HDL. By disposing cellular lipids they
prevent lipid accumulation and the concomitant induction of
apoptosis and inflammatory responses [84]. In this report we show
that mye-macrophages have an increased efflux of cholesterol to
HDL. These results demonstrate that the upregulation of genes
involved in cholesterol efflux is functional and suggest that mye-
macrophages protect themselves from the pro-apoptotic and pro-
inflammatory effects of intracellular lipid accumulation by
promoting cholesterol efflux.
As mentioned earlier, LXRs are cholesterol sensors controlling
intracellular and systemic cholesterol homeostasis [85,86]. How-
ever, apart from regulating cholesterol metabolism, they inhibit
inflammatory gene expression in macrophages [46–50]. As 25% of
the lipid content in myelin consists of cholesterol, it is likely that
myelin-rich macrophages and microglia in neurodegenerative,
demyelinating disorders like MS, display a phenotype which is in
part dictated by a myelin-mediated activation of LXRs [87]. In
this study we demonstrate that myelin contains ligands capable of
activating LXRb, hereby affecting the expression of LXR response
genes like ABCA1 and the secretion of inflammatory mediators
like IL-6. Interestingly, LXR activation has been demonstrated to
ameliorate EAE by modulating T cell polarization [88–90].
Moreover, an increased expression of LXRb in peripheral blood
mononuclear cells in MS patients was described to counteract T
cell proliferation [91]. Our finding that myelin activates LXRs
suggests an additional role of these receptors in naturally occurring
Figure 3. Myelin and T0901317 affect the expression of LXR response genes in a similar manner. (a–c) Comparison of fold changes of
LXR response genes between untreated (dotted line) and myelin- or T0901317-treated macrophages. Macrophages were treated for 24 and 48 hours
with 100 mg/ml myelin or 10 mM T0901317 after which expression of ApoE and ABCA1/G1 was determined. Relative quantification of gene expression
was accomplished by using the comparative Ct method. Data were normalized to the most stable reference genes, determined by Genorm (18S and
PGK-1). Data represent the mean of four independent experiments. (d) Comparison of fold changes of ABCA1 between untreated (dotted line) and
myelin treated wild-type, LXRa-, LXRb- and LXRab-deficient mouse macrophages. Macrophages were treated 48 hours with 100 mg/ml myelin. Data
were normalized to the most stable reference genes, determined by Genorm (CycA and HMBS). Data represent the mean of four independent
experiments. Mye; Myelin: T09; T0901317.
doi:10.1371/journal.pone.0044998.g003
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regulatory mechanisms in macrophages during demyelination.
Future studies should determine whether, besides LXR activation,
other pathways that modulate the phenotype of macrophages are
activated by lipids or proteins present in myelin.
To date, despite the abundance of lipids in myelin, most studies
have mainly focused on the role of myelin proteins in demyelin-
ating diseases. Our data indicate a role for myelin-derived lipids in
modulating the metabolic and inflammatory response in macro-
phages during demyelination. Although mye-macrophages have a
decreased secretion of NO and IL-6, the microarray did not point
towards a typical M2 phenotype. These results are in line with a
recent report showing that macrophages treated with oxidized
phospholipids, so called mox-macrophages, adopt a novel
phenotype that differs from conventional M1 and M2 phenotypes
[92]. Although both mye- and mox-macrophages induce pathways
involved in chemotaxis and phagocytosis, other characteristic
genes in mox-macrophages were not differentially expressed in
mye-macrophages. The latter indicates that mye-macrophages
obtain a specific phenotype, divergent from M1, M2 and mox-
macrophages. Future studies are required to elucidate the
importance of lipid metabolism in directing the macrophage
phenotype and function, and thereby the influence of lipids in MS
lesion pathology.
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